Dural prostate metastasis presenting as a subdural hematoma.

Area of Science:

• Neurosurgery
• Oncology
• Pathology

Background:

• Subdural hematoma (SDH) affects approximately 13.1 per 100,000 individuals annually.
• Metastatic disease involving the skull and dura mater is an infrequent cause of SDH.

Observation:

• A 71-year-old male patient with a history of prostate adenocarcinoma presented with symptoms suggestive of chronic subdural hematoma.
• Diagnostic imaging confirmed the presence of subdural hematoma.

Findings:

• The subdural hematoma was determined to be a consequence of metastasis from the prostate adenocarcinoma to the skull bone and dura mater.
• This represents a rare etiological pathway for subdural hematoma.

Implications:

• This case underscores the importance of considering metastatic disease in the differential diagnosis of subdural hematoma, particularly in patients with a known cancer history.
• Further research into the mechanisms and management of neoplastic-induced subdural hematoma is warranted.